The pain relief market gets squeezed
"There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance." she said
Across 2,339 adults with obesity or overweight, all three doses of retatrutide met the primary and key secondary endpoints at 80 weeks
However, controlled clinical trials directly testing structured cycle-synchronized dietary patterns remain scarce, limiting the ability to draw causal conclusions
It interacts with areas of the brain that control hunger and fullness, helping people feel less hungry and more satisfied with smaller meals
It has completed phase 1b/2a trials as of January 2025